News

Analyst: Biotech Expecting a ‘Catalyst-Rich’ Second Half of the Year

May 14, 2021 (Investorideas.com Newswire) An H.C. Wainwright & Co. report discusses Gritstone Bio’s recent earnings and significant corporate events as the firm plans to release data on cancer and COVID-19 vaccines later this year.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News

Next Article:

0 %